GIP and type 2 diabetes mellitus: Increasing evidence strongly indicates that T2DM and obese subjects develop hormone resistance and diminished GPCR-dependent signaling mediated by the three preproglucagon-derived hormones, glucagon, GLP-1, and GIP.